Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.
Salarinia R, Sahebkar A, Peyvandi M, Mirzaei HR, Jaafari MR, Riahi MM, Ebrahimnejad H, Nahand JS, Hadjati J, Asrami MO, Fadaei S, Salehi R, Mirzaei H.
Salarinia R, et al. Among authors: sahebkar a.
Curr Cancer Drug Targets. 2016;16(9):773-788. doi: 10.2174/1568009616666151207110143.
Curr Cancer Drug Targets. 2016.
PMID: 26638884
Review.